FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic - FDA Press Releases

FDA approved Descovy in at-risk adults and adolescents for HIV-1 pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection from sex, excluding those who have receptive vaginal sex.

from FDA Press Releases RSS Feed https://ift.tt/2V9jdl2
via IFTTT